Skip to content

Clinical trials

Phase 3 Lymphoma, Mantle-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 3 Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20025
20033
20043
20052
20063
20073
20086
20094
20104
20122
20133
20141
20163
20173
20191
20214
20221
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Unknown status18
Active, not recruiting6
Recruiting5
Terminated4
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center5
German High-Grade Non-Hodgkin's Lymphoma Study Group4
Alliance for Clinical Trials in Oncology3
European Organisation for Research and Treatment of Cancer - EORTC3
Janssen Research & Development, LLC3
Jonsson Comprehensive Cancer Center3
Memorial Sloan Kettering Cancer Center3
Acerta Pharma BV2
BeOne Medicines2
Celgene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell81
Lymphoma, Non-Hodgkin50
Lymphoma, Large B-Cell, Diffuse46
Lymphoma, Follicular45
Leukemia, Lymphocytic, Chronic, B-Cell41
Burkitt Lymphoma38
Lymphoma, B-Cell, Marginal Zone38
Lymphoma, Large-Cell, Immunoblastic37
Lymphoma36
Precursor Cell Lymphoblastic Leukemia-Lymphoma36

Trials

Showing 76 to 81 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.